A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure
Clinical trial NCT02914665 · COMPLETED
Trial details
- NCT number
- NCT02914665
- Sponsor
- Stealth BioTherapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-20
- Primary completion
- 2017-11-27
- Enrollment
- 308
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.